Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with AnalystsBusiness Wire • 12/18/25
Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?Zacks Investment Research • 12/17/25
Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling BackBenzinga • 12/17/25
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin EligibilityPRNewsWire • 12/17/25
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 12/16/25
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue ForecastThe Motley Fool • 12/16/25
Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.Barrons • 12/16/25
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 GuidanceBusiness Wire • 12/16/25
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 millionReuters • 12/15/25
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with PfizerGlobeNewsWire • 12/15/25
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?The Motley Fool • 12/14/25